Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Chen Jianmin¹^ORCID,Jiang Feng²,Zhao Chenyan³,Chai Jing¹,Li Lanshu³,Guan Qinghu²,Li Xiaoyu³,Wang Feiyu¹^ORCID,Li Ansheng⁴,Gao Hongxia⁵,Wang Minghui¹^ORCID,Fu Liandi⁴,Nie Fei¹^ORCID,Ling Weijun⁶,Deng Haobin⁷^ORCID,Zhou Lei¹^ORCID

Affiliation:

1. General Manager Office, Dalian Aleph Biomedical Co Ltd, Dalian, China

2. Institute of Immunization Program, Guizhou Center for Disease Control and Prevention, Guiyang, China

3. Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), Beijing, China

4. Influenza Vaccine Production Workshop, Dalian Aleph Biomedical Co Ltd, Dalian, China

5. Quality Control Department, Dalian Aleph Biomedical Co Ltd, Dalian, China

6. Scientific Affairs Department, Simoon Record Beijing Co Ltd, Beijing, China

7. Department of Bases Development, Simoon Record Beijing Co Ltd, Beijing, China

Funder

Research and Development

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2245721

Reference23 articles.

1. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection

2. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review

3. Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region

4. Vaccines against influenza WHO position paper – November 2012;French PMID;Wkly Epidemiol Rec,2012

5. Influenza-associated disease burden in mainland China: a systematic review and meta-analysis